Abaloparatide vs Calcitonin
Overview
Abaloparatide and Calcitonin are both bone & joint peptides, but they differ in mechanism, dosing, and regulatory status.
This page compares Abaloparatide and Calcitonin across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Abaloparatide | Calcitonin | |
|---|---|---|
| Category | Bone & Joint | Bone & Joint |
| Regulatory status (US) | Research use only | Research use only |
| Typical dosage | 80 mcg | 100-200 IU |
| Frequency | daily | daily |
| Reported benefits | Bone building, osteoporosis treatment, reduced fracture risk | Reduced bone loss, pain relief in bone diseases |
| Reported side effects | Similar to teriparatide but milder | Nasal irritation (spray form), nausea |
Key differences
Primary use. Abaloparatide is categorised under Bone & Joint, while Calcitonin falls under Bone & Joint. Because they target a similar goal, they are common alternatives to weigh against each other.
Regulatory status. Abaloparatide: not FDA-approved; treated as a research compound. Calcitonin: not FDA-approved; treated as a research compound.
Dosing. Abaloparatide is typically dosed at 80 mcg (daily). Calcitonin is typically dosed at 100-200 IU (daily).
Can you stack them?
Some protocols combine peptides, but stacking Abaloparatide and Calcitonin has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Abaloparatide and Calcitonin?
- Abaloparatide and Calcitonin are both bone & joint peptides, but they differ in mechanism, dosing, and regulatory status. Abaloparatide is not FDA-approved; generally classified as a research compound, whereas Calcitonin is not FDA-approved; generally classified as a research compound.
- What is Abaloparatide used for?
- Advanced bone anabolic.
- What is Calcitonin used for?
- FDA-approved bone resorption inhibitor.
- Can you take Abaloparatide and Calcitonin together?
- Some users combine peptides within a single protocol, but stacking Abaloparatide and Calcitonin has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Abaloparatide or Calcitonin FDA-approved?
- Abaloparatide is not FDA-approved; generally classified as a research compound. Calcitonin is not FDA-approved; generally classified as a research compound.
Read the full articles
- Abaloparatide — full monograph: mechanism, research, dosing & references
- Calcitonin — full monograph: mechanism, research, dosing & references